Melanoma, or malignant melanoma, is a highly aggressive cancer that develops in melanocytes. Many genes have been found to be mutated or amplified in melanoma, with the most commonly mutated genes being BRAF, CDKN2A, NRAS and TP53. MAPK and PI3K/Akt signaling are central to melanoma.
This pathway is a summary of information from figures 1 and 2 from [Kunz and Vera](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520749/) and supplemented with information from [KEGG](https://www.kegg.jp/dbget-bin/www_bget?pathway+hsa05218).
CDKN2A is frequently mutated in melanoma and germline mutations are associated with an increased susceptibility of developing skin cancer. The CDKN2A encodes two proteins, p16 (INK4A) and p14ARF, with different functions. p16 binds to CDK4, which prevents phosphorylation of Rb, thereby controlling the G1 to S transition. Without functioning p16, G1 to S transition can proceed. p14ARF is central to cell cycle regulation, inhibiting MDM2, which normally degrades p53, so loss of p14ARF has a similar effect to loss of p53.
Protein phosphorylation sites were added based on information from PhosphoSitePlus (R), www.phosphosite.org.
fabca0cb6d7ab44a2fb44cb5b44b44d64afe"The RhoA subfamily (RhoA, RhoB, and RhoC) of GTPases [...] In melanoma the RhoA subfamily, especially RhoC, promotes invasion and metastasis 5, 22, 50, and inhibition of the RhoA isoform suppresses tumor growth" Source: https://doi.org/10.1038/s41388-019-1074-1e15a2feabHomology Mapping from Mus musculus to Homo sapiens: Original ID = L:18706Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:18708Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:18709Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:74769Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:18707Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:75669Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:11651Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:23797Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:11652SOS1; son of sevenless homolog 1 (Drosophila)Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:12015Homology Mapping from Mus musculus to Homo sapiens: Original ID = L:19211fabCDK6; cyclin-dependent kinase 6 [EC:2.7.1.-]CDK4; cyclin-dependent kinase 4 [EC:2.7.1.-]CCND3; cyclin D3E2F1; E2F transcription factor 1E2F2; E2F transcription factor 2E2F3; E2F transcription factor 3Alternate reading frame product of CDKN2Ap16 INK4aCDK4; cyclin-dependent kinase 4 [EC:2.7.1.-]CCND3; cyclin D3E2F1; E2F transcription factor 1E2F2; E2F transcription factor 2E2F3; E2F transcription factor 3e20V600Eparentid=P04049; parentsymbol=RAF1; site=IGDFGLAtVksRWsG; position=thr491; sitegrpid=447748; ptm=p; direction=uparentid=Q02750; parentsymbol=MAP2K1; site=LIDsMANsFVGTRSY; position=ser222; sitegrpid=448513; ptm=p; direction=uparentid=Q02750; parentsymbol=MAP2K1; site=VsGQLIDsMANsFVG; position=ser218; sitegrpid=448514; ptm=p; direction=uparentid=P28482; parentsymbol=MAPK1; site=HtGFLtEyVAtRWyR; position=tyr187; sitegrpid=447594; ptm=p; direction=uparentid=P28482; parentsymbol=MAPK1; site=HDHtGFLtEyVAtRW; position=thr185; sitegrpid=447593; ptm=p; direction=uparentid=P27361; parentsymbol=MAPK3; site=HDHtGFLtEyVAtRW; position=thr202; sitegrpid=447542; ptm=p; direction=uparentid=P27361; parentsymbol=MAPK3; site=HtGFLtEyVAtRWyR; position=tyr204; sitegrpid=447543; ptm=p; direction=uparentid=P36507; parentsymbol=MAP2K2; site=LIDsMANsFVGTRSY; position=ser226; sitegrpid=448074; ptm=p; direction=uparentid=P36507; parentsymbol=MAP2K2; site=VsGQLIDsMANsFVG; position=ser222; sitegrpid=448073; ptm=p; direction=uparentid=Q92934; parentsymbol=BAD; site=EIRsRHssyPAGtED; position=ser75; sitegrpid=447860; ptm=p; direction=dparentid=P24385; parentsymbol=CCND1; site=EEVDLACtPtDVRDV; position=thr286; sitegrpid=447839; ptm=p; direction=dparentid=Q14247; parentsymbol=CTTN; site=KtQtPPVsPAPQPtE; position=Ser405; sitegrpid=447700; ptm=p; direction=uparentid=Q14247; parentsymbol=CTTN; site=tEErLPssPVyEDAA; position=Ser418; sitegrpid=447701; ptm=p; direction=uparentid=Q9UPT5; parentsymbol=EXOC7; site=sSSGVPysPAIPNKR; position=Ser250; sitegrpid=483909; ptm=p; direction=ucb0parentid=P06400; parentsymbol=RB1; site=AVIPINGsPRtPRRG; position=ser249; sitegrpid=447975; ptm=p; direction=db05d60d60d6dd6021946352PubMedExon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma.Nat Genet2011Prickett TDWei XCardenas-Navia ITeer JKLin JCWalia VGartner JJiang JCherukuri PFMolinolo ADavies MAGershenwald JEStemke-Hale KRosenberg SAMargulies EHSamuels Y27650545PubMedSHP2 phosphatase as a novel therapeutic target for melanoma treatment.Oncotarget2016Zhang RYYu ZHZeng LZhang SBai YMiao JChen LXie JZhang ZY40872623PubMedMolecular Basis of BRAF Inhibitor Resistance in Melanoma: A Systematic Review.Pharmaceuticals (Basel)2025Cosci ISalizzato VDel Fiore PPigozzo JGuarneri VMocellin SFerlin AMathlouthi SPiccin LGarofalo Mhsa05218KEGG Pathwayhttps://www.kegg.jp/dbget-bin/www_bget?pathway+hsa0521819718025PubMedAnalysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.Nat Genet2009Prickett TDAgrawal NSWei XYates KELin JCWunderlich JRCronin JCCruz PRosenberg SASamuels Y26091043PubMedGenomic Classification of Cutaneous Melanoma.Cell201522595671PubMedERK1/2 regulate exocytosis through direct phosphorylation of the exocyst component Exo70.Dev Cell2012Ren JGuo WPMC5031419PubMedNon-overlapping Clinical and Mutational Patterns in Melanomas from the Female Genital Tract and Atypical Genital Nevi Journal of Investigative Dermatology2016Yelamos OMerkel EMeldi Sholl LZhang BAmin SLee CGuitart GYang JWenzel ABunick CYazdan PChoi JGerami P9529249PubMedARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.Cell1998Zhang YXiong YYarbrough WGcancer pathwayPW:0000605Pathway Ontologydisease pathwayPW:0000013Pathway Ontology22453014PubMedTherapeutic implications of KIT in melanoma.Cancer J2012Postow MACarvajal RD22842228PubMedExome sequencing identifies recurrent somatic RAC1 mutations in melanoma.Nat Genet2012Krauthammer MKong YHa BHEvans PBacchiocchi AMcCusker JPCheng EDavis MJGoh GChoi MAriyan SNarayan DDutton-Regester KCapatana AHolman ECBosenberg MSznol MKluger HMBrash DEStern DFMaterin MALo RSMane SMa SKidd KKHayward NKLifton RPSchlessinger JBoggon TJHalaban RmelanocyteCL:0000148Cell Type16001072PubMedIntegrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.Nature2005Garraway LAWidlund HRRubin MAGetz GBerger AJRamaswamy SBeroukhim RMilner DAGranter SRDu JLee CWagner SNLi CGolub TRRimm DLMeyerson MLFisher DESellers WR31659259PubMedRho-mediated signaling promotes BRAF inhibitor resistance in de-differentiated melanoma cells.Oncogene2020Misek SAAppleton KMDexheimer TSLisabeth EMLo RSLarsen SDGallo KANeubig RR22817889PubMedA landscape of driver mutations in melanoma.Cell2012Hodis EWatson IRKryukov GVArold STImielinski MTheurillat JPNickerson EAuclair DLi LPlace CDicara DRamos AHLawrence MSCibulskis KSivachenko AVoet DSaksena GStransky NOnofrio RCWinckler WArdlie KWagle NWargo JChong KMorton DLStemke-Hale KChen GNoble MMeyerson MLadbury JEDavies MAGershenwald JEWagner SNHoon DSSchadendorf DLander ESGabriel SBGetz GGarraway LAChin LmelanomaDOID:1909Disease30987166PubMedModelling of Protein Kinase Signaling Pathways in Melanoma and Other Cancers.Cancers (Basel)2019Kunz MVera J22622578PubMedMelanoma genome sequencing reveals frequent PREX2 mutations.Nature2012Berger MFHodis EHeffernan TPDeribe YLLawrence MSProtopopov AIvanova EWatson IRNickerson EGhosh PZhang HZeid RRen XCibulskis KSivachenko AYWagle NSucker ASougnez COnofrio RAmbrogio LAuclair DFennell TCarter SLDrier YStojanov PSinger MAVoet DJing RSaksena GBarretina JRamos AHPugh TJStransky NParkin MWinckler WMahan SArdlie KBaldwin JWargo JSchadendorf DMeyerson MGabriel SBGolub TRWagner SNLander ESGetz GChin LGarraway LA